Table 1.

Demographic features of the patients at the time of molecular analysis.

PatientSexAge at Onset, yrsAge at Molecular Analysis, yrsMutations in NLRP3 or in Other Genes
S1F3041Q703K
S2F4560Q703K
S3F2226Q703K
S4F711Q703K
S5F421Q703K
S6M1725Q703K
S7F1519Q703K
S8F5758Q703K
S9F2828Q703K
S10F5764Q703K
S11M3343Q703K
S12F1023Q703K
S13F3338Q703K
S14M1545Q703K
S15M641Q703K
S16M88Q703K
S17F16Q703K
S18F18Q703K
S19F17Q703K
S20M19Q703K
S21F316Q703K
S22F47Q703K
S23M33Q703K
S24M11Q703K
S25M11Q703K
S26M24Q703K-M406I
S27F2937Q703K
S28F1416Q703K
S29M311Q703K
S30M11Q703K
S31M2123Q703K
S32F11Q703K
S33M56Q703K/V726A (MEFV)
S34M15Q703K
S35F12Q703K
S36F11Q703K-D303N+ V198M